Physician profile
Jonathan S Daitch
NPI 1215924154
$38,732.59
in general payments reported to CMS, 2019-2025
57 companies · $9,955 in 2025
The $9,955 reported for 2025 was more than what 95% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $1,710 · 2021: $2,798 · 2022: $3,944 · 2023: $3,975 · 2024: $5,882 · 2025: $9,955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $4,063 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,176 · Entertainment: $70.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,503.19 |
| Travel and Lodging | $4,062.63 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,176.25 |
| Entertainment | $70.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,723.11 | 2019-2025 | Intracept, General - Pain Management, Wavewriter Alpha Prime 16 |
| Biodelivery Sciences International, INC. | $6,028.10 | 2019-2021 | |
| Spinefrontier, INC. | $4,984.51 | 2025 | Sijfuse, Inspan, Nanofuse |
| Relievant Medsystems, INC. | $3,087.90 | 2020-2023 | Intracept |
| Spinal Simplicity, LLC | $2,942.58 | 2023-2025 | Ha Minuteman G3-R |
| Vertiflex, INC. | $1,700.47 | 2019 | |
| Abbvie INC. | $1,178.82 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Foundation Fusion Solutions, LLC | $1,057.44 | 2023-2025 | |
| Abbott Laboratories | $800.14 | 2019-2024 | Proclaim, Eterna |
| Tersera Therapeutics LLC | $764.73 | 2019-2025 | Prialt |
| Nevro Corp. | $668.12 | 2019-2021 | |
| Amgen INC. | $528.59 | 2019-2024 | Evenity, Prolia |
| Vertos Medical, INC. | $507.42 | 2019-2024 | Mild Device Kit |
| Allergan, INC. | $427.01 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $398.75 | 2019-2024 | Ztlido |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Daitch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.